Professional Documents
Culture Documents
Alteration in Metabolism and Endocrine System
Alteration in Metabolism and Endocrine System
1. Congenital Hypothyroidism
- Thyroid hypofunction causes reduced production of both T4 and T3.
- Congenital hypofunction (reduced or absent function) occurs as a result of an absent or
nonfunctioning thyroid gland in a newborn.
- The cause of the disorder is usually unknown.
- The condition may not be noticeable initially, because the mother’s thyroid hormones maintain
adequate levels in the fetus during pregnancy.
Clinical Manifestations
- Symptoms: first 3 months of life in a formula-fed infant and at about 6 months in a breastfed
infant.
- Progressive physical and cognitive challenges.
- Child sleeps excessively.
- The tongue becomes enlarged, causing respiratory difficulty, noisy respirations, or obstruction.
- The child may suck poorly because of sluggishness or choking.
- The skin of the extremities usually feels cold, and the overall body temperature may be
subnormal because of slowed metabolism.
- A slow metabolic rate is also revealed by slow pulse and respiratory rates.
- Prolonged jaundice may be present, due to the immature liver’s inability to conjugate bilirubin.
- The child’s neck appears short and thick.
- The facial expression becomes dull, as the result of becoming cognitively challenged, and open-
mouthed because of the child’s attempts to breathe around the enlarged tongue.
- The extremities appear short and fat, with hypotonic muscles, giving the infant a floppy, rag-doll
appearance.
- Deep tendon reflexes are decreased from normal.
- Generalized obesity usually occurs. Hair is brittle and dry.
- Dentition is delayed, or teeth may be defective when they do erupt. An ultrasound reveals a
small or absent thyroid gland.
- The hypotonia affects the intestinal tract as well, so the infant develops chronic constipation;
the abdomen enlarges because of intestinal distention and poor muscle tone.
- Many infants have an umbilical hernia.
- Overall, the skin is dry and perhaps scaly, and the child does not perspire.
Diagnostic Evaluation
- Newborn Screening.
- A screening test for hypothyroidism is mandatory at birth (using the same few drops of blood
obtained for a Guthrie or phenylketonuria [PKU] test).
- Infants have low radioactive iodine uptake levels, low serum T4 and T3 levels, and elevated
thyroid-stimulating factor.
- Blood lipids are increased. Radiographs may reveal delayed bone growth.
Therapeutic Management
- Oral administration of synthetic thyroid hormone, sodium levothyroxine.
- A small dose is given at first, and then the dose is gradually increased to therapeutic levels.
- The child needs to continue taking medication indefinitely to supplement that which the thyroid
does not make.
- Supplemental vitamin D may also be given to prevent the development of rickets, with the
administration of thyroid hormone, rapid bone growth begins.
- Further cognitive challenges can be prevented as soon as therapy is started, but any degree of
impairment that is already present cannot be reversed.
Clinical Manifestations
- In response to TSH, hypertrophy of the thyroid gland (goiter) occurs.
- Body growth is impaired by lack of thyroxine.
- In infants, congenital goiter can lead to airway obstruction.
- In children, prominent symptoms are obesity, lethargy, and delayed sexual development. –
- Antithyroid antibodies will be present in serum if the illness was caused by an autoimmune
process.
- The thyroid not only enlarges but may become nodular in response to the oversecretion of TSH.
Diagnostic Evaluation
- Children are administered radioactive iodine.
- If the nodes are benign, there is generally a rapid uptake of radioactive iodine (“hot nodes”).
- If there is no uptake (“cold nodes”), carcinoma is a much more likely diagnosis (rare at this age).
Therapeutic Management
- Administration of synthetic thyroid hormone (sodium levothyroxine), the same as for congenital
hypothyroidism.
- With adequate dosage, the obesity diminishes and growth begins again.
Clinical Manifestations
- Graves’ disease often follows a viral illness or a period of stress.
- With overproduction of T3 and T4, children gradually experience nervousness, loss of muscle
strength, and easy fatigue.
- Their basal metabolic rate is high; blood pressure and pulse are increased.
- They perspire freely.
- They are always hungry, and, although they eat constantly, they do not gain weight and may
even lose weight because of the increased basal metabolic rate.
- Exophthalmos.
Diagnostic Evaluation
- On radiography, bone age appears advanced beyond the chronologic age of the child.
- The thyroid gland, which usually is not prominent in children, appears as a swelling on the
anterior neck (goiter) - This enlargement can be confirmed by ultrasound.
- When the child protrudes the tongue or extends the hands, fine tremors are noticeable.
- Laboratory tests show elevated T4 and T3 levels and increased radioactive iodine uptake.
- TSH is low or absent because the thyroid is being stimulated by antibodies, not by the pituitary
gland.
Therapeutic Management
- Therapy consists first of a course of a beta-adrenergic blocking agent, such as propranolol, to
decrease the antibody response.
- After this, child is placed on an antithyroid drug, such as propylthiouracil (PTU) or methimazole
(Tapazole), to suppress the formation of thyroxine.
- While the child is taking these drugs, the blood is monitored for leukopenia (decreased white
blood cell count) and thrombocytopenia (decreased platelet count), side effects of the drugs.
- If either of these results, the drug is discontinued until the white blood cell or platelet count
returns to normal, so the child does not develop an infection or experience spontaneous
bleeding.
- It takes about 2 weeks for these drugs to have an effect.
- The child usually has to take the drug for 2 to 3 years before the condition “burns itself out.
- If the child has a toxic reaction to medical management (severely lowered white blood cell count
or platelet count) or is noncompliant about taking the medicine, radioiodine ablative therapy
with 131I to reduce the size of the thyroid gland can be accomplished.
- Surgical removal of part or almost all of the thyroid gland, which may be necessary in a young
adult.
- After both radioiodine ablative therapy and thyroidectomy, supplemental thyroid hormone
therapy may be needed indefinitely because the gland is no longer able to produce an adequate
amount.
- It is important that adolescent girls be carefully regulated before they consider childbearing as
high hyperthyroidism during pregnancy can lead to hypothyroidism in a fetus.
State a possible expected outcome and enumerate the related nursing interventions based on the
identified nursing diagnosis.
Nursing Diagnosis: Situational low self-esteem related to lack of coordination and presence of prominent
goiter
Expected outcome:
Related interventions:
Levothyroxine - Action:
Nursing respomsibilities:
Adrenal hormones
- Consists of 2 distinct portions:
Cortex – outer section, secretes hormones called steroids which are essential to life.
secretes 3 groups of hormones;
1. Glucocorticoids (cortisol, corticostirone)
2. Mineralocorticoids (aldosterone)
3. Sex steroids ( androgens, estrogens, and progestins.
Clinical Manifestations
- Blood pressure drops to extremely low levels.
- Child appears ashen gray and may be pulseless.
- Temperature becomes elevated.
- Dehydration and hypoglycemia (an abnormally low concentration of blood glucose) are marked.
- Sodium and chloride blood levels are very low.
- Serum potassium is elevated, because there is usually an inverse relationship between sodium
and potassium values.
- Seizures may occur.
- Without treatment, death can occur abruptly.
Diagnostic Evaluation
- There is no rapid, definitive test for confirmation of acute adrenocortical insufficiency.
- The diagnosis is usually made based on clinical presentation.
- Improvement with cortisol therapy confirms the diagnosis.
Therapeutic Management
- Immediate replacement of cortisol (with IV hydrocortisone sodium succinate [Solu-Cortef]).
- Administration of deoxycorticosterone acetate (DOCA), the synthetic equivalent of aldosterone;
and IV 5% glucose in normal saline solution to restore blood pressure, sodium, and blood
glucose levels.
- A vasoconstrictor may be necessary to elevate the blood pressure further.
- Acute adrenocortical insufficiency is a medical emergency. Although it is seen less often now
than in the past, because of the availability of antibiotics that quickly halt the course of
infectious disease, it is not an obsolete entity.
Clinical Manifestations
Glucocorticoid
- Fasting hypoglycemia: headache, diaphoresis, weakness, trembling, hunger, seizures.
- Decreased gastric acidity: anorexia, nausea, vomiting.
- Fatigue: increased sleeping, listlessness
- Psychologic symptoms: irritability, apathy, negativism
Mineralocorticoid
- Muscle weakness
- Weight loss
- Fatigue
- GI symptoms
- Nutritional symptoms: salt craving
- Circulatory: hypotension, fainting, dizziness
- Electrolyte imbalance: hyperkalemia, hyponatremia, acidosis
- Psychologic symptoms: irritability, apathy, negativism
Androgen deficiency
- Integumentary: Decreased pubic hair and axillary hair
- Psychologic: decreased libido
Diagnostic Evaluation
- Definitive diagnosis is based on measurements of functional cortisol reserve.
- Cortisol and urinary 17-hydroxycorticosteroid levels are low and fail to rise while plasma ACTH
levels are elevated with corticotropin (ACTH) stimulation – the definitive test for the disease.
Therapeutic Management
- Replacement of glucocorticoids (cortisol) and mineralocorticoids (aldosterone).
- Oral replacements of cortisol (cortisone or hydrocortisone preparations) with a liberal intake of
salt.
- During stressful situations such as fever, infection, emotional upset, or surgery, the dosage must
be tripled to accommodate the body’s increased need for glucocorticoids.
- Failure to meet the requirement will precipitate an acute crisis.
- Overdosage produces appearance of cushingoid signs.
- Other forms of therapy: monthly injections of desoxycorticosterone acetate or implantation of
desoxycorticosterone acetate pellets subcutaneously every 9 to 12 months.
3. Cushing’s Syndrome
- Caused by overproduction of the adrenal hormone cortisol; this usually results from increased
ACTH production due to a pituitary tumor.
- It may occur from a malignant or benign tumor of the adrenal cortex.
- The peak age of occurrence is 6 or 7 years, but the syndrome can occur as early as infancy.
- Children who receive high doses of synthetic corticosteroids, such as prednisone, over a long
period may develop the same symptoms as those observed in Cushing syndrome.
- Cushingoid appearance.
- Cushing syndrome is often suspected as the cause of obesity in children, and some obese
children do have elevated levels of plasma corticosteroids, a fact that complicates the diagnosis.
Clinical Manifestations
- Overproduction of cortisol results in increased glucose production; this causes fat to accumulate
on the cheeks, chin, and trunk, causing a moon-faced, stocky appearance.
- Cortisol is catabolic, so protein wasting occurs → muscle wasting, making the extremities
appear thin.
- Loss of protein matrix in bones → osteoporosis (loss of calcium in bones).
- Cortisol also suppresses the immune system, so humoral immunity is decreased, → children
susceptible to infection.
- It causes vasoconstriction, so extreme hypertension may occur.
- Hyperpigmentation occurs from the melanin-stimulating properties of ACTH. →causes the
child’s face to be unusually red, especially the cheeks.
- Signs of abnormal masculinization or feminization may occur from accompanying
overproduction of androgen or estrogen.
- Purple striae resulting from collagen deficit appear on the child’s hips, abdomen, and thighs,
similar to those seen in pregnancy.
- Polyuria develops as the body tries to excrete increased glucose levels.
- Growth ceases, if the condition is not reversed before the epiphyseal lines close, short stature
results. .
- Children with natural obesity are generally tall; those with Cushing syndrome are short.
Diagnostic Evaluation
- Dexamethasone suppression test confirms the diagnosis. If a child without the syndrome is
given a test dose of dexamethasone (a glucocorticoid), the plasma level of adrenal cortisol will
fall. It will not fall in children with adrenocortical tumors, because the tumor continues to
stimulate the adrenal glands to oversecretion.
- If cosyntropin (Cortrosyn), a synthetic corticotropin, or ACTH is administered, plasma cortisol
levels will normally rise. In patients with an adrenal tumor, the gland is already functioning at
full capacity, so no cortisol elevation occurs.
- CT scan or ultrasound reveals the enlarged adrenal or pituitary gland, confirming the diagnosis.
Therapeutic Management
- Treatments depends on the cause.
- Surgical intervention - bilateral adrenalectomy and postoperative replacement of the cortical
hormones.
- For pituitary tumor – surgical extirpation or irradiation.
- Treatment of panhypopituitarism with replacement of GH, thyroid extract, ADH, gonadotropins,
and steroids.
Nursing Care Management
- When cushingoid features are caused by steroid therapy, the effects may be lessened with
administration of the drug early in the morning and on an alternate-day basis. Giving the drug
early in the day maintains the normal diurnal pattern of cortisol secretion.
- An alternate-day schedule allows the anterior pituitary an opportunity to maintain more normal
hypothalamic-pituitary-adrenal control mechanisms.
- If given during evening – more likely to produce symptoms because endogenous cortisol levels
are already low and the additional supply exerts more pronounced effects.
Clinical Manifestations
- Excessive androgens → masculinization of the urogenital system at the 10 th week of fetal
development.
- Most pronounced abnormalities occur in the girl (ambiguous genitalia).
- Masculinization of external genitalia causes the clitoris to enlarge (appears as a small phallus).
- Fusion of the labia produces a saclike structure resembling the scrotum without testes.
- Males do not display abnormalities at birth.
- Increased pigmentation of skin creases & genitalia caused by increased ACTH
- Salt-wasting crisis within a first few weeks of life; infants fail to gain weight, and hyponatremia
at birth.
- Untreated CAH – early sexual maturation with enlargement of the external sexual organs,
development of axillary, pubic hair, and facial hair; deepening of the voice; acne; and marked
increased in musculature with changes toward an adult male physique.
- However, breast do not develop in the female, and remains amenorrheic and infertile.
- Male testes remain small, and spermatogenesis does not occur.
- In both sexes – linear growth is accelerated, & epiphyseal closure is premature, resulting in short
stature by the end of puberty.
Diagnostic Evaluation
- Initially based on congenital abnormalities that lead to difficulty assigning sex to the newborn
and on signs and symptoms of adrenal insufficiency or hypertension.
- Definitive diagnosis confirmed by evidence of increased 17-ketosteroid levels.
- Chromosome typing for positive sex determination to rule out any other genetic abnormality.
- Ultrasonography – to visualize the presence of pelvic structures; identifies the absence or
presence of female reproductive organs in a newborn or child with ambiguous genitalia.
Therapeutic Management
- Initial medical objective – confirm the diagnosis and assign a sex to the child.
- In both sexes – cortisone is administered to suppress the abnormally high secretions of ACTH.
- If cortisone is given early – very effective.
- Cortisone depress the secretion of ACTH by adenohypophysis – which in turn inhibits the
secretion of adrenocorticosteroids, which stems the progressive virilization.
- The recommended oral dosage is divided to stimulate the normal diurnal pattern of ACTH
secretion.
- Children with the salt-losing type of CAH require aldosterone replacement.
- Depending on the degree of masculinization in the female, reconstructive surgery may be
required to reduce the size of the clitoris, separate the labia, and create a vaginal orifice.
Rob has his adrenal gland function assessed. What is the effect on a child when sufficient aldosterone
cannot be produced?
a. Substantially fewer red blood cells are produced.
b. There is an overall decreased urine output.
c. An excessive amount of sodium is lost in urine.
d. The child’s growth rate increases abnormally.
3. Phenylketonuria
- PKU is a disease of metabolism that is inherited as an autosomal recessive trait.
- Absence of the liver enzyme phenylalanine hydroxylase prevents conversion of phenylalanine,
an essential amino acid, into tyrosine (a precursor of epinephrine, thyroxine, and melanin).
- As a result, excessive phenylalanine builds up in the bloodstream and tissues, causing
permanent damage to brain tissue and leaving children severely cognitively challenged.
- The metabolite phenylpyruvic acid (a breakdown product of phenylalanine) spills into the urine
to give the disorder its name.
- Characterized by blood phenylalanine levels greater than 8mg/dl (normal level is less than
2mg/dl, 2to5 days after birth.
- The child fails to meet average growth standards because of the lack of thyroxine production.
- PKU is found in 1 of every 10,000 births in the United States.
- If the condition remains untreated, the child with PKU usually will have an IQ below 20.
Clinical Manifestations
- In all children:
o Digestive problem and vomiting
o Seizures
o Musty odor of the urine odor that is so strong, it often pervades not only the urine but
the entire child.
- In older children:
o Eczema
o Hypertonia
o Hypopigmentation of the hair, skin, and irises. (Tyrosine is necessary for building
body pigment and is incorporated into thyroxine. Without it, body pigment fades
and the child becomes very fair skinned, light blonde haired, and blue eyed)
o Hyperactive behavior.
Diagnostic Evaluation
- Early identification of the disorder is essential to prevent the child from becoming severely
cognitively challenged.
- Infants are screened at birth after receiving 2 full days of feedings (at least 120 mL of formula at
a concentration of 20 calories per ounce, or the equivalent amount obtained by breastfeeding).
- The screening is done by pricking the infant’s heel with a blood lancet and letting a few drops of
blood fall onto a specially prepared filter paper.
- The filter paper is then analyzed by a bacterial inhibition process for the amount of
phenylalanine contained in the infant’s blood (the Guthrie test).
- PKU cannot be detected by amniocentesis or percutaneous umbilical cord blood sampling as a
routine screening measure, because the phenylalanine level does not rise in utero, while the
infant is still under the control of the mother’s enzyme system.
- Recombinant DNA techniques can be used for carrier detection and prenatal diagnosis.
- If an infant is born at home or is discharged from a hospital or birthing center before the second
day of life, the parents will need to have the test performed on the second or third day after
birth.
- If there is a question as to whether a breastfed baby has received only colostrum, a repeated
Guthrie test should be performed by the second week of life, during a health care visit.
Therapeutic Management
- Infants in whom this disease is detected during the first few days of life are placed on a formula
that is extremely low in phenylalanine, such as Lofenalac.
- Beginning the diet early helps to keep the child from becoming cognitively challenged.
- A dietitian may recommend that a small amount of milk be added to the infant’s diet every day
so the child does receive some phenylalanine (this essential amino acid is necessary for growth
and repair of body cells).
- A mother who wants to breastfeed may be able to do so on a limited basis. Parents of children
with PKU need a realistic prognosis of their child’s potential.
- Providing nutrition for a child with PKU is a difficult task.
- There is no natural protein with both a low phenylalanine concentration and normal levels of
other essential amino acids.
- Unfortunately, amino acid formulas have a rather disagreeable taste.
- As children grow older and have solid foods added to their meals, these foods also must be low
in phenylalanine so that the phenylalanine level of the child’s blood stays below 8 mg/dL.
- Foods highest in phenylalanine are those that are rich in protein, such as meats, eggs, and milk.
- Foods low in phenylalanine include orange juice, bananas, potatoes, lettuce, spinach, and peas.
- Lofenalac can be used to prepare treat foods, such as ice cream, milk shakes, birthday cakes,
and puddings (foods that would otherwise be forbidden because they are made with milk).
- Children need their blood and urine monitored frequently for phenylalanine levels.
- Hemoglobin levels should also be closely monitored to ensure that the child is not becoming
anemic, because iron is found primarily in protein-rich foods, which the child must avoid.
- Most people with G6PD deficiency usually don't experience any symptoms. However, some may
develop symptoms when they’re exposed to the medication, food, or infection that triggers the
early destruction of red blood cells.
- Once the underlying cause is treated or resolved, symptoms of G6PD deficiency usually
disappear within a few weeks.
Clinical Manifestations
- rapid heart rate
- shortness of breath
- urine that is dark or yellow-orange
- fever
- fatigue
- dizziness
- paleness
- jaundice, or yellowing of the skin and whites of the eye
Diagnostic Evaluation
- Simple blood test to check G6PD enzyme levels.
- Other diagnostic tests that may be done include a complete blood count, serum hemoglobin
test, and a reticulocyte count. All these tests give information about the red blood cells in the
body. They can also help to diagnose hemolytic anemia.
Therapeutic Management
- Treatment for G6PD deficiency consists of removing the trigger that is causing symptoms.
- If the condition was triggered by an infection, then the underlying infection is treated
accordingly. Any current medications that may be destroying red blood cells are also
discontinued. In these cases, most people can recover from an episode on their own.
- Once G6PD deficiency has progressed to hemolytic anemia, more aggressive treatment may be
required - includes oxygen therapy and a blood transfusion to replenish oxygen and red blood
cell levels.
Nursing Care Management
- The best way to care for a child with G6PD deficiency is to limit exposure to anything that
triggers symptoms.
5. Galactosemia
- Disorder of carbohydrate metabolism that is characterized by abnormal amounts of galactose in
the blood (galactosemia) and in the urine (galactosuria).
- It occurs in about 1 in every 60,000 births, most often as an inborn error of metabolism,
transmitted as an autosomal recessive trait.
- The child is deficient in the liver enzyme galactose-1-phosphate uridyltransferase.
- Lactose (the sugar found in milk) normally is broken down into galactose and glucose; galactose
is then further broken down into additional glucose. Without the galactose 1-phosphate
uridyltransferase enzyme, this second step, the conversion of galactose into glucose, cannot
take place, and galactose builds up in the bloodstream and spills into the urine. When it reaches
toxic levels in the bloodstream, it destroys body cells.
Clinical Manifestations
- Symptoms appear as soon as the child begins formula feeding or breastfeeding and include
lethargy, hypotonia, and perhaps diarrhea and vomiting.
- The liver enlarges as cirrhosis develops.
- Jaundice is often present and persistent; bilateral cataracts develop.
- The symptoms begin abruptly and worsen rapidly.
- If the condition remains untreated, a child may die by 3 days of age.
- Untreated children who survive beyond this time may be cognitively challenged and have
bilateral cataracts.
Diagnostic Evaluation
- Diagnosis is made by measuring the level of the affected enzyme in the red blood cells.
- A screening test (the Beutler test) can be used to analyze cord blood if a child is known to be at
risk for the disorder.
- Increased galactose in the blood.
- Decreased levels of uridine diphosphate (UDP).
Therapeutic Management
- The treatment of galactosemia consists of placing the infant on a diet that is free of galactose or
on a formula made with milk substitutes such as casein hydrolysates (Nutramigen).
- Eliminating all milk and lactose containing foods, including breast milk.
- Use of lactose-free formula with soy-protein.
- Supportive treatment and care are implemented, monitoring for hypoglycemia, liver failure,
bleeding disorders, and E. coli sepsis.
- Once the child’s condition is regulated on this diet, symptoms of the disease do not progress;
however, any neurologic or cataract damage that is already present will persist, (long term
neurologic complications –ovarian dysfunction, abnormal speech, cognitive impairment,
hypergonadotropic hypogonadism, growth retardation, and impaired motor function).
Clinical Manifestations
- Infants who have the disorder appear well at birth but quickly begin to show signs of feeding
difficulty, loss of the Moro reflex, and irregular respirations.
- The symptoms progress rapidly to opisthotonus, generalized muscular rigidity, and seizures.
- If the condition remains untreated, an infant may die of the disease as early as 2 to 4 weeks of
age.
- By the first or second day of life, the urine of the child develops the characteristic odor of maple
syrup; hence the name of the disease.
- The odor is caused by the presence of ketoacids, the same phenomenon that makes the breath
of diabetic children in severe acidosis smell sweet.
Diagnostic Evaluation
- Infants are screened at birth for the disorder. (Newborn screening).
- Prenatal detection is possible by analyzing cells obtained by amniocentesis.
Therapeutic Management
- If maple syrup urine disease is diagnosed during the first day or two of life and the child is placed
on a well-controlled diet that is high in thiamine and low in the amino acids leucine, isoleucine,
and valine, the cerebral degeneration can be prevented, just as it can be prevented in PKU.
- Hemodialysis or peritoneal dialysis can be used to temporarily reduce abnormal serum levels at
birth or during a childhood infection, when catabolism of cells releases increased amino acids
into the bloodstream.
Learning activity:
1. What if... You are helping at a preschool and notice a teacher assistant urging a little boy
with PKU to drink his milk? When you suggest that milk might not be good for him, the
teacher says, “Of course it is. Milk is nature’s perfect food.” How would you respond? What
would you do?
NOTE:
FOR THE MULTIPLE CHOICE, PLEASE INCLUDE RATIONALE FOR YOUR ANSWER.